Exact Sciences Corporation
Government Contracts & Awards
NOISS Exact Sciences
$259,047Proprietary Tech & Patents
NUCLEIC ACID CONTROL MOLECULES FROM NON-HUMAN ORGANISMS
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
Abbott Laboratories: Reasonably Valued After Surge, But Still An Attractive Buy Long-Term
Abbott stays a buy after Q2 beat/raise; Exact Sciences boosts growth. Click for more on ABT stock.
Abbott Laboratories: Pick Up This Dividend King Deal Now
Abbott Laboratories' strength in Medical Devices business and the recently acquired Exact Sciences should keep driving growth. Read why ABT stock is a buy.
Abbott’s cancer diagnostics vision: ‘There’s always a hunger to make these tests better’
Jorge Garces, who joined Abbott to oversee scientific strategy for cancer diagnostics after it acquired Exact Sciences, discusses the future of the field.
Abbott Laboratories Q2 Earnings Preview: A Contrarian Buy Opportunity Worth Considering
Abbott is upgraded to Buy ahead of Q2 2026 earnings: Exact Sciences deal boosts cancer diagnostics growth as 2026 guidance improves. Click to read more.
Mounting Evidence Backs Abbott's Cancer Diagnostics Growth Story
ABT's Exact Sciences acquisition expands its cancer diagnostics portfolio as new data and screening guidelines strengthen growth prospects.
Abbott Laboratories: A Better Than 5 Years Ago - But Still Not A Buy
Abbott (ABT) looks fairly valued after a 26% drop. See Q1 results, Exact Sciences deal impact, debt/EPS dilution risks, and dividend outlook. See more here.
Abbott’s Lingo Wearable And Cardio R&D Reframe Long Term Growth Story
Abbott Laboratories (NYSE:ABT) is expanding its presence in health tech with new diagnostics and wearable products, including the Lingo biomarker monitoring device. The company is also increasing R&D activity in cardiovascular diagnostics, aiming to broaden its role in earlier detection and ongoing monitoring of heart related conditions. These product moves come as attention on Abbott has recently centered on earnings, insider activity, and the Exact Sciences acquisition rather than its...
Key People
No individuals linked to this entity yet.
Political Giving
$3,500 given to 2 candidates across 2 disclosed contributions (FEC Schedule A).
Terri A. Sewell
Scott H. Peters
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro